The global electroceuticals market is expected to grow at a CAGR of 7.1% during the forecast period. The global electroceuticals market is expected to grow significantly owing to various factors such as rising incidence and prevalence rate of chronic diseases, and growing investment for the development of advanced electroceuticals by major players as well as the government. Increasing prevalence of neurological disorders such as epilepsy, Parkinson’s, Paraneoplastic Neurologic Syndrome, migraine, have resulted in an increasing focus of the players in the development of electroceuticals.



Get Free Sample Copy @

https://www.omrglobal.com/request-sample/electroceuticals-market


The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By End-user segment, the market is segmented into hospitals & clinics and homecare and other. Few players operating in the global electroceuticals market include Medtronic PLC, Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp.



Browse for Full Report at:

https://www.omrglobal.com/industry-reports/electroceuticals-market



5. Market Segmentation

5.1. Global Electroceuticals Market by Product and its Application
5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker
5.1.1.1. Arrhythmias
5.1.2. Deep Brain Stimulators
5.1.2.1. Parkinson’s Disease
5.1.2.2. Depression
5.1.3. Spinal Cord Stimulators
5.1.3.1. Failed Back Syndrome
5.1.3.2. Ischemia
5.1.4. Vagus Nerve Stimulators
5.1.4.1. Epilepsy
5.1.5. Cochlear Implants
5.1.5.1. Sensorineural Hearing Loss
5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
5.1.6.1. Urinary Incontinence
5.1.6.2. Treatment-Resistant Depression



5.2. Global Electroceuticals Market by End-User
5.2.1. Hospitals and Clinics
5.2.2. Homecare and Other



6. Regional Analysis

6.1. North America
6.1.1. United States
6.1.2. Canada



6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe



6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific

6.4. Rest of the World



7. Company Profiles

7.1. Abbott Laboratories Inc.
7.2. Advanced Bionics AG
7.3. Aleva Neurotherapeutics SA
7.4. Axonics Modulation Technologies Inc.
7.5. BioElectronics Corp.
7.6. Biotronik
7.7. Boston Scientific Corp.
7.8. Cala Health Inc.
7.9. Cigna Corp.
7.10. Cochlear Ltd
7.11. Demant A/S
7.12. Edwards Lifesciences Corp.
7.13. Electrocore Inc.
7.14. Functional Neuromodulation Ltd.
7.15. Getinge AB
7.16. GlaxoSmithKline PLC
7.17. Lepu Medical Co. Ltd.
7.18. Livanova PLC
7.19. Medtronic PLC
7.20. NeuroPace, Inc.
7.21. Nevro Corp.
7.22. Nurotron Biotechnology Co. Ltd.
7.23. Nuvectra Corp.
7.24. Renishaw PLC
7.25. Second Sight Medical Products Inc.
7.26. Sonova Holding AG
7.27. Stimwave LLC
7.28. Terumo Corp.
7.29. ZOLL Medical Corp.




For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/electroceuticals-market





About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404